Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
91.07
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jun 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
55
56
Next >
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
↗
Today 2:05 EDT
For a solid yield and strong upside potential, this pharmaceutical stock is worth considering.
Via
The Motley Fool
Topics
Intellectual Property
Stocks
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't
↗
June 03, 2026
This particular sector may suit cautious and aggressive investors.
Via
The Motley Fool
3 Beaten-Down Stocks to Buy and Hold Forever
↗
June 02, 2026
Don't wait too long to buy the dip on these stocks.
Via
The Motley Fool
Topics
World Trade
Abbott Laboratories (NYSE:ABT) Presents a Decent Value Opportunity After 21% Pullback
↗
May 08, 2026
Via
Chartmill
Top gainers and losers in the S&P500 index during Thursday's after-hours session.
↗
May 28, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's after-hours session.
↗
May 28, 2026
Via
Chartmill
3 Monster Dividend Stocks to Hold for the Next 10 Years
↗
May 24, 2026
These stocks are built for the long haul. And they pay great dividends.
Via
The Motley Fool
Topics
Energy
Intellectual Property
Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market
↗
May 22, 2026
This big pharma stock checks off a lot of boxes.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
3 Stocks to Buy if You Think the Economy Is Heading for a Recession
↗
May 21, 2026
They have increased their payouts for a combined 171 years straight.
Via
The Motley Fool
Topics
Economy
Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
↗
May 13, 2026
See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.
Via
MarketBeat
Topics
Artificial Intelligence
This Dividend ETF May Be the Ultimate Income Investment to Put in Your Portfolio Right Now
↗
May 12, 2026
The Schwab U.S. Dividend Equity ETF checks off all the key boxes investors are likely going to want from a top dividend investment.
Via
The Motley Fool
Topics
ETFs
Sell in May and Go Away—Starting With These 3 Stocks
↗
May 12, 2026
Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call.
Via
MarketBeat
Topics
Artificial Intelligence
What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk
↗
May 10, 2026
This mortgage REIT generates income by originating and managing commercial real estate loans across the United States.
Via
The Motley Fool
Topics
Regulatory Compliance
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress
↗
May 10, 2026
Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends.
Via
The Motley Fool
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?
↗
May 06, 2026
They have combined for 118 years of consecutive dividend increases.
Via
The Motley Fool
Topics
Intellectual Property
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week Lows
↗
May 06, 2026
These stocks pay more than double the S&P 500 average and have modest valuations relative to the overall market.
Via
The Motley Fool
Topics
Economy
Stocks
Want Reliable Dividend Income in May? These 2 Stocks Deliver
↗
May 06, 2026
These stocks check off multiple boxes for income investors.
Via
The Motley Fool
Topics
Economy
Intellectual Property
This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?
↗
May 03, 2026
A rare yield, Dividend King status, and a steady healthcare business may be creating one of its most interesting income setups in years.
Via
The Motley Fool
1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever
↗
May 02, 2026
This company, which has raised its dividend for 54 consecutive years, is on sale.
Via
The Motley Fool
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?
↗
April 29, 2026
Via
MarketBeat
How to Pick a Healthcare Stock That Can Weather Any Market
↗
April 28, 2026
How does a nearly 3% (and growing) dividend yield sound?
Via
The Motley Fool
Topics
Economy
World Trade
This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio
April 23, 2026
Abbott Labs is a balance of income and growth.
Via
Barchart.com
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
↗
April 20, 2026
They offer investors very different value propositions.
Via
The Motley Fool
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount
↗
April 20, 2026
Various concerns weighed on appetite for stocks in recent weeks.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond
↗
April 19, 2026
These stocks pay juicy dividends but also offer much more.
Via
The Motley Fool
Topics
Economy
Abbott Stock Crash: Rebound Could Be Coming Fast
↗
April 17, 2026
Via
MarketBeat
Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earnings
↗
April 17, 2026
Abbott Laboratories (NYSE:ABT) reported upbeat Q1 earnings but lowered its 2026 outlook, including dilution from Exact Sciences acquisition.
Via
Benzinga
TSMC's Chip Heat Extends the Record Run, Then Netflix Drops a Double Surprise After the Bell
↗
April 17, 2026
Via
Chartmill
Why Abbott Laboratories Stock Tumbled on Thursday
↗
April 16, 2026
It essentially met analyst expectations for its inaugural quarter of 2026.
Via
The Motley Fool
Which S&P500 stocks are moving on Thursday?
↗
April 16, 2026
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
55
56
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
